In Brief: ICN Pharmaceuticals
Executive Summary
ICN Pharmaceuticals: Devron Averett, PhD, to corporate senior VP-R&D. He was head of Glaxo Wellcome's Department of Molecular & Cellular Virology, with 20 years at Burroughs Wellcome. Averett will lead the development of nucleic acid-based therapies...